Uploaded by dime4cme on Mar 30, 2011
CME/CE Information
Release Date: March 1, 2011
Expiration Date: March 1, 2012
Earning CME Credit
If you are interested in obtaining CME/CE credit for this session, please access the activity at http://www.ejournalclub.org/viewdiscussion.aspx?id=38. You will need to register and launch the activity prior to being able to complete the evaluation & posttest.
Accreditation Statement
DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
DIME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Activity Purpose
To recognize the integral role of a lifestyle intervention, including diet and increased physical activity, for achieving weight loss and reducing cardiovascular risk factors in overweight or obese patients with type 2 diabetes mellitus
Target Audience
This activity is directed to endocrinologists, primary care physicians, internists, and other healthcare professionals who manage and treat patients with T2DM
Funding Statement
Diabetes eJournal Club is supported by an educational grant from Amylin Pharmaceuticals, Inc, and Lilly USA LLC.
Sponsorship
Diabetes eJournal Club is sponsored by DIME.
Faculty and Disclosures
DIME requires that all persons who were in a position to control or influence the content of this CME activity disclose all relevant financial relationships with any commercial interest. This information is used to: (1) determine whether a conflict exists, (2) resolve the conflict by initiating a content validation process, and (3) advise learners of this information.
Frank Svec, MD, PhD
Sources of Funding for Research: None
Consulting Agreements: None
Speakers Bureau/Honorarium Agreements: Novartis Pharmaceutical Corp
Financial Interest/Stock Ownership: None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
Rena R. Wing, PhD, has nothing to disclose
Nancy Moran has nothing to disclose
Inquiries
All inquiries should be directed to:
DIMEinfo@dimeded.org
© 2011 DIME
-
0 likes, 0 dislikes
14:26
Diabetes eJournal 3-11 part 3by dime4cme21 views
14:57
Diabetes eJournal 3-11 part 1by dime4cme37 views
9:40
Positive Role Model: Part - 1by DrTommyO24 views
6:06
Dangerous Pharmaceutical Side-effectsby AMolvar1,022 views
5:09
Presentation of our company/ Юля Серикby Stanislav1964545 views
58:00
Biomarkers for Type 2 Diabetes Preventionby UCtelevision1,676 views
3:16
Sapna - South Asian Pharma Network of Americasby Sapnaonline598 views
7:02
Diabetes, Exercise and Your Risk for Coronary Artery Diseaseby cardiotabs913 views
5:03
Unintened Effects of FDA Diabetes Guidelines - Alogliptin Case.movby pharmapricing168 views
1:00
Byetta Commercial- Better Control of Your Diabetesby DiaTribeNews14,535 views
2:19
Nocturna XXL 2nd edition aftermovieby MissCannibalKitten1,828 views
1:55
New Drug to Treat Type 1 and Type 2 Diabetes (May 2005)by LawsuitGuru1,227 views
0:49
Sandoz Pharmaceuticals/Colors and Chemicals Commercialby bkdurham1,302 views
2:08
Flagship Educational Activity Centre to Open in South Yorkshireby RadioLynxContent1,624 views
3:36
CNC Stomp 1 - CNC Project Introduction - Learn CNC Cuttingby ivanirons27,225 views
6:29
Militarizing Healthcare/Banks Paid Not to Lendby goharrison8,922 views
1:26
Lifestyle intervention on Type 2 Diabetesby WMARabc2news31 views
2:00
Help FDA Stop "Bad Ads"by USFoodandDrugAdmin2,138 views
1:41:41
White House Forum on Intellectual Property Theft (Part 1)by whitehouse6,703 views
1:25:01
Biotechnology, Diagnostics, and Genomics: Panel Discussionby stanfordbusiness2,308 views
- Loading more suggestions...
All Comments